GENZYME (NASDAQ:GENZ)

View All ReportsStreetInsider.com Reports on GENZ

Feb 8, 2010 07:33 AM Goldman Sachs Removed Genzyme (GENZ) from Conviction Sell List, Adds St. Jude (STJ)

Feb 3, 2010 08:53 AM UBS Upgrades Genzyme (GENZ) to Buy, Boosts Target to $68

Feb 1, 2010 09:33 AM Morgan Joseph Adds Spectrum Pharmaceuticals (SPPI) to Trading List; Expect Strong Growth From Zevalin

Jan 21, 2010 10:26 AM Genzyme (GENZ) Receives Six-Month PDUFA from U.S. FDA for Lumizyme BLA

Jan 21, 2010 10:25 AM Genzyme's (GENZ) Lumizyme Receives 6-Month FDA Review; Date Set for June 17

View All Press ReleasesCompany Press Releases on GENZ

Feb 3, 2010 09:12AM Scott Canute Joins Genzyme to Head Manufacturing and Corporate Operations

Jan 29, 2010 09:20AM Genzyme Strengthens Role of Board's Lead Independent Director

Jan 28, 2010 08:30AM Genzyme Adopts New Incentive Compensation Plans for Senior Executives

Jan 21, 2010 10:21AM Genzyme's Lumizyme BLA Receives Six-Month FDA Review

Jan 19, 2010 08:00AM PTC Therapeutics Announces Additional Study of Ataluren in Patients with Advanced Nonsense Mutation Duchenne/Becker Muscular Dystrophy

StreetInsider Reports on GENZ by Category

• Analyst Ratings
• Mergers and Acquisitions
• Earnings
• Guidance
• Stock Buybacks
• Dividends
• Retail Sales
• Management Changes
• Insider Trades
• View More Categories

View All BlogsBlogs on GENZ

Feb 9, 2010 05:43 AM Percentage of Oversold Stocks at Highest Level Since March 2009

Feb 9, 2010 04:52 AM Weekly Street Sentiment: Sell-Side Still Searching for Direction

Feb 8, 2010 01:05 PM Analyst upgrades, downgrades and initiations: CME, AZO, XOM, DNB, GENZ

Feb 2, 2010 12:16 PM Another Setback for Protalix

Jan 25, 2010 05:17 AM Genzyme's Outlook Stabilizing

View All FilingsSEC Filings on GENZ

Jan 29, 2010 04:02PM Form SC 13G GENZYME CORP Filed by: BlackRock Inc.

Jan 28, 2010 08:31AM Form 8-K GENZYME CORP For: Jan 22

Jan 12, 2010 11:59AM Form 8-K GENZYME CORP For: Jan 12

Jan 7, 2010 08:47AM Form 8-K GENZYME CORP For: Jan 06

Jan 5, 2010 11:49AM Form 4 GENZYME CORP For: Dec 31 Filed by: BERTHIAUME DOUGLAS A

View All Comments Comments on recent GENZ articles

Hedgie
on Jan 6, 2010
at 05:59 PM GILD Man, that Morgan Stanley analyst sure hates him some Gilead. He may or may not be right about the pipeline, but the share price already reflects his concerns and then some.
Article: Morgan Stanley Gives a Preview for Biotech's Q4 Earnings (GILD, CELG, BIIB, GENZ, More...)

M. Smernov
on Nov 28, 2009
at 05:59 AM The 20K foot view of PLX Uplyso will be the first bio-generic, but the real value is in the validation of the concept that PLX will be able to copy a lot of existing patented bio drugs using their pro-cell technology and not violate patent laws. This could be THE game changer in bio-drugs. I am long PLX, and price targets are meaningless. All I can say is that if Uplyso gets final approval, the stock will move so fast is will make your head swim.
Article: Canaccord Adams Maintains a 'Buy' on Protalix BioTherapeutics (PLX); Cerezyme Supply on Track, See More Uplyso EAP Uptake

a yahav
on Nov 27, 2009
at 11:57 AM PLX target price With their estimate of a minimum of 15% market share the target price should be at least about 26 $ and not 13!
Article: Canaccord Adams Maintains a 'Buy' on Protalix BioTherapeutics (PLX); Cerezyme Supply on Track, See More Uplyso EAP Uptake

Ken
on Nov 19, 2009
at 10:11 AM PLX Why is this stock down over the last week?
Article: Protalix BioThera (PLX) May Have a Winner with Gaucher Drug prGCD

Iki
on Sep 2, 2009
at 05:15 PM $10 is under esstimation !! Would like to emphsize that the holders can easily get more than $1B for FDA approved company, while $1B represent $13 of 76MM outstanding stocks. Profesionals can tell that the holder will not give up the company for much more...
Article: Hapoalim Securities Initiates Coverage on Protalix BioTherapeutics (PLX) with an Outperform; Attractive Entry Point

Comments on GENZ

No comments are currently available.

Name

Subject

Body

Verification can't see the text?
click here to refresh the image.
what's this?